Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.

Ghosh, Nilasha; Couette, Nina; van Binsbergen, Wouter H; Weinmann, Sophia C; Jivanelli, Bridget; Shea, Beverley; Bass, Anne R; Benesova, Karolina; Bingham, Clifton O; Calabrese, Cassandra; Cappelli, Laura C; Chan, Karmela Kim; Choy, Ernest; Daoussis, Dimitrios; Goodman, Susan; Hudson, Marie; Jamal, Shahin; Leipe, Jan; Lopez-Olivo, Maria A; Suarez-Almazor, Maria; van der Laken, Conny J; Meara, Alexa Simon; Liew, David F L; Kostine, Marie

doi:10.1016/j.semarthrit.2022.152110

Title

Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.

Publication Date

2023

Author(s)

Ghosh, Nilasha

Couette, Nina

van Binsbergen, Wouter H

Weinmann, Sophia C

Jivanelli, Bridget

Shea, Beverley

Bass, Anne R

Benesova, Karolina

Bingham, Clifton O

Calabrese, Cassandra

Cappelli, Laura C

Chan, Karmela Kim

Choy, Ernest

Daoussis, Dimitrios

Goodman, Susan

Hudson, Marie

Jamal, Shahin

Leipe, Jan

Lopez-Olivo, Maria A

Suarez-Almazor, Maria

van der Laken, Conny J

Meara, Alexa Simon

Liew, David F L

Kostine, Marie

Subject

ICI-induced inflammatory arthritis

ICI-induced polymyalgia rheumatica

Immune checkpoint inhibitor

Outcome measures

Type of document

Journal Article

OrcId

#PLACEHOLDER_PARENT_METADATA_VALUE#

DOI

10.1016/j.semarthrit.2022.152110

Abstract

Immune checkpoint inhibitors (ICI), increasingly used cancer therapeutics, can cause off-target inflammatory effects called immune-related adverse events (irAEs), including ICI-induced inflammatory arthritis (ICI-induced IA) and polymyalgia rheumatica (ICI-induced PMR). There are no validated classification criteria or outcome measures for these conditions, and adaptation of treatment recommendations from corresponding rheumatic diseases may not be appropriate. We summarized clinical descriptors of ICI-induced IA and ICI-induced PMR and aggregated domains used for these conditions in order to inform the development of a core set of outcome domains.

Link

link

Citation

Seminars in Arthritis and Rheumatism 2023

Jornal Title

Seminars in Arthritis and Rheumatism

ISSN

1532-866X

Austin Health

Files: